logo

For the Inventor, By the Inventor

Bad Homburg, Germany

Arthur Scherm

USPTO Granted Patents = 11

Average Co-Inventor Count = 1.9

ph-index = 7

Forward Citations = 157(Granted Patents)


Company Filing History:

goldMedal8 out of 10 
 
Merz & Co.
 patents
silverMedal3 out of 23 
 
Merz+co. Gmbh & Co.
 patents

Years Active: 1977-1991

Loading Chart...
11 patents (USPTO):Explore Patents
1. 4981869 - Xanthates as antitumor agents (1991-01-01),
2. 4758581 - Pyridyl N-oxides (1988-07-19),
3. 4602037 - Xanthates and antiviral use thereof (1986-07-22),
4. 4412998 - Certain 4-(1-piperidino)-phenyl-nicotinates (1983-11-01),
5. 4370330 - Method of enhancing circulation with piperazines (1983-01-25),
6. 4370329 - Piperazine derivatives as circulation-enhancing substances (1983-01-25),
7. 4323548 - Vaginal suppository for contraception, having a predetermined (1982-04-06),
8. 4321268 - Certain substituted phenyl esters of nicotinic acid, compositions and (1982-03-23),
9. 4273774 - Central nervous system compositions and method (1981-06-16),
10. 4122193 - Drugs or medicines for influencing the central nervous system (1978-10-24),
11. 4051143 - Process for the production of (1977-09-27),

Title: Discovering the Innovations of Inventor Arthur Scherm

Introduction

Arthur Scherm, a prolific inventor based in Bad Homburg, Germany, holds an impressive portfolio of 11 patents. His contributions primarily focus on novel compounds with significant implications in the fields of oncology and virology. Scherm's dedication to innovation has established him as a respected figure within the scientific community.

Latest Patents

Among his most recent patents, Arthur Scherm has developed xanthate compounds that serve as potent antitumor and antiviral agents. These patents detail not only the compounds themselves but also a comprehensive process for their production and applications in pharmaceutical compositions aimed at combating various viruses and tumors. Additionally, he has patented pyridyl N-oxides, which are associated with the treatment of hyperlipidemias. The patent outlines the manufacturing process, the specific chemical compositions involved, and their therapeutic uses.

Career Highlights

Throughout his career, Arthur Scherm has made substantial contributions while working at renowned companies such as Merz & Co. and Merz+Co. GmbH & Co. His work has significantly advanced the understanding of biochemical compounds and their potential therapeutic applications, showcasing his commitment to improving public health through innovation.

Collaborations

Scherm’s collaborative efforts with fellow researchers, including Dezsoe Peteri and Klaus W. Hummel, have enriched his work and expanded the potential applications of his inventions. These partnerships have facilitated groundbreaking research and development in diverse areas of pharmaceutical sciences.

Conclusion

Arthur Scherm's innovative spirit and dedication to research have resulted in significant advancements in the treatment of various medical conditions. With his extensive patent portfolio and collaborative efforts, he continues to make a lasting impact on the field of pharmaceutical development. As he forges ahead, the scientific community eagerly anticipates the future contributions that Scherm will make in the realm of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…